• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌红蛋白和血红蛋白的过氧化物酶活性、它们的病理后果以及可能的医学干预。

The peroxidatic activities of Myoglobin and Hemoglobin, their pathological consequences and possible medical interventions.

机构信息

School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, Essex, CO4 3SQ, UK.

出版信息

Mol Aspects Med. 2022 Apr;84:101045. doi: 10.1016/j.mam.2021.101045. Epub 2021 Oct 13.

DOI:10.1016/j.mam.2021.101045
PMID:34654576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8837633/
Abstract

Under those pathological conditions in which Myoglobin and Hemoglobin escape their cellular environments and are thus separated from cellular reductive/protective systems, the inherent peroxidase activities of these proteins can be expressed. This activity leads to the formation of the highly oxidizing oxo-ferryl species. Evidence that this happens in vivo is provided by the formation of a covalent bond between the heme group and the protein and this acts as an unambiguous biomarker for the presence of the oxo ferryl form. The peroxidatic activity also leads to the oxidation of lipids, the products of which can be powerful vasoconstrictive agents (e.g. isoprostanes, neuroprostanes). Here we review the evidence that lipid oxidation occurs following rhabdomyolysis and sub-arachnoid hemorrhage and that the products formed from arachidonic acid chains of phospholipids lead, through vasoconstriction, to kidney failure and brain vasospasm. Intervention in these pathological conditions through administration of reducing agents to remove ferryl heme is discussed. Through-protein electron transfer pathways that facilitate ferryl reduction at low reductant concentration have been identified. We conclude with consideration of the therapeutic use of Hemoglobin Based Oxygen carriers and how the toxicity of these may be reduced by engineering such electron transfer pathways into hemoglobin.

摘要

在肌红蛋白和血红蛋白从其细胞环境中逸出并因此与细胞还原/保护系统分离的病理条件下,这些蛋白质固有的过氧化物酶活性可以被表达。这种活性导致高度氧化的氧合铁物种的形成。体内发生这种情况的证据是血红素基团与蛋白质之间形成共价键,这是氧合铁形式存在的明确生物标志物。过氧化物酶活性也导致脂质的氧化,其产物可以是强大的血管收缩剂(例如,异前列腺素,神经前列腺素)。在这里,我们回顾了肌红蛋白尿和蛛网膜下腔出血后发生脂质氧化的证据,以及磷脂中花生四烯酸链形成的产物通过血管收缩导致肾衰竭和脑血管痉挛。通过向患者施用还原剂以去除铁血红素来干预这些病理条件的方法正在被讨论。已经确定了在低还原剂浓度下促进铁血红素还原的蛋白内电子转移途径。最后,我们考虑了血红蛋白基氧载体的治疗用途,以及如何通过工程设计将这些电子转移途径引入血红蛋白来降低其毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/93a9a7f59e95/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/c115a3589f24/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/60154d397582/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/58324597415c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/0edc9e61219f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/dca163882fd8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/93a9a7f59e95/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/c115a3589f24/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/60154d397582/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/58324597415c/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/0edc9e61219f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/dca163882fd8/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf46/8837633/93a9a7f59e95/gr6.jpg

相似文献

1
The peroxidatic activities of Myoglobin and Hemoglobin, their pathological consequences and possible medical interventions.肌红蛋白和血红蛋白的过氧化物酶活性、它们的病理后果以及可能的医学干预。
Mol Aspects Med. 2022 Apr;84:101045. doi: 10.1016/j.mam.2021.101045. Epub 2021 Oct 13.
2
Hemoglobin and myoglobin associated oxidative stress: from molecular mechanisms to disease States.血红蛋白和肌红蛋白相关的氧化应激:从分子机制到疾病状态
Curr Med Chem. 2005;12(23):2741-51. doi: 10.2174/092986705774463021.
3
Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering nontoxic blood substitutes.酪氨酸残基作为人类血红蛋白中的氧化还原辅因子:对构建无毒血液替代品的启示。
J Biol Chem. 2008 Nov 7;283(45):30780-7. doi: 10.1074/jbc.M804709200. Epub 2008 Aug 26.
4
The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology.肌红蛋白和血红蛋白的自由基与氧化还原化学:从体外研究到人类病理学
Antioxid Redox Signal. 2004 Dec;6(6):954-66. doi: 10.1089/ars.2004.6.954.
5
Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.将酪氨酸残基工程化到血红蛋白中可增强血红素还原,减少氧化应激,并增加基于血红蛋白的血液代用品的血管保留。
Free Radic Biol Med. 2019 Apr;134:106-118. doi: 10.1016/j.freeradbiomed.2018.12.030. Epub 2018 Dec 27.
6
A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure.肌红蛋白的氧化还原循环及其碱化抑制在横纹肌溶解诱导的肾衰竭发病机制和治疗中的致病作用。
J Biol Chem. 1998 Nov 27;273(48):31731-7. doi: 10.1074/jbc.273.48.31731.
7
Pro-oxidative characteristics of trout hemoglobin and myoglobin: a role for released heme in oxidation of lipids.虹鳟鱼血红蛋白和肌红蛋白的促氧化特性:释放的血红素在脂质氧化中的作用。
J Agric Food Chem. 2005 Dec 28;53(26):10231-8. doi: 10.1021/jf051923m.
8
Nature of the ferryl heme in compounds I and II.化合物 I 和 II 中高铁血红素的性质。
J Biol Chem. 2011 Jan 14;286(2):1260-8. doi: 10.1074/jbc.M110.183483. Epub 2010 Nov 8.
9
The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms.血红蛋白的氧化还原活性:从生理功能到病理机制。
Antioxid Redox Signal. 2010 Oct 1;13(7):1087-123. doi: 10.1089/ars.2009.2974.
10
Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure.对乙酰氨基酚抑制血红素蛋白催化的脂质过氧化反应,减轻横纹肌溶解导致的肾衰竭。
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2699-704. doi: 10.1073/pnas.0910174107. Epub 2010 Feb 1.

引用本文的文献

1
New Approaches and Strategies for the Repurposing of Iron Chelating/Antioxidant Drugs for Diseases of Free Radical Pathology in Medicine.铁螯合/抗氧化药物在医学中用于自由基病理疾病的重新利用的新方法和策略。
Antioxidants (Basel). 2025 Aug 10;14(8):982. doi: 10.3390/antiox14080982.
2
Impact of Rhabdomyolysis on Clinical Outcomes in Patients With Acute Myocardial Infarction.横纹肌溶解对急性心肌梗死患者临床结局的影响。
Cureus. 2025 Jul 1;17(7):e87142. doi: 10.7759/cureus.87142. eCollection 2025 Jul.
3
Major heme proteins hemoglobin and myoglobin with respect to their roles in oxidative stress - a brief review.

本文引用的文献

1
βCysteine 93 in human hemoglobin: a gateway to oxidative stability in health and disease.β-半胱氨酸 93 位在人类血红蛋白中:健康与疾病中氧化稳定性的关键。
Lab Invest. 2021 Jan;101(1):4-11. doi: 10.1038/s41374-020-00492-3. Epub 2020 Sep 26.
2
Engineering hemoglobin to enable homogenous PEGylation without modifying protein functionality.对血红蛋白进行工程改造,以实现均匀聚乙二醇化而不改变蛋白质功能。
Biomater Sci. 2020 Jul 21;8(14):3896-3906. doi: 10.1039/c9bm01773a. Epub 2020 Jun 15.
3
Engineering tyrosine residues into hemoglobin enhances heme reduction, decreases oxidative stress and increases vascular retention of a hemoglobin based blood substitute.
主要血红素蛋白血红蛋白和肌红蛋白在氧化应激中的作用——简要综述
Front Chem. 2025 Feb 25;13:1543455. doi: 10.3389/fchem.2025.1543455. eCollection 2025.
4
Boosting nutritional value: the role of iron fortification in meat and meat products.提高营养价值:铁强化在肉类及肉制品中的作用。
Biometals. 2025 Apr;38(2):337-355. doi: 10.1007/s10534-024-00659-1. Epub 2025 Jan 21.
5
The Roles of Oxidative Stress and Red Blood Cells in the Pathology of the Varicose Vein.氧化应激和红细胞在静脉曲张病理过程中的作用
Int J Mol Sci. 2024 Dec 13;25(24):13400. doi: 10.3390/ijms252413400.
6
Ferroptosis as an emerging target in sickle cell disease.铁死亡作为镰状细胞病的一个新兴靶点。
Curr Res Toxicol. 2024 Jun 18;7:100181. doi: 10.1016/j.crtox.2024.100181. eCollection 2024.
7
Modulation of the Human Erythrocyte Antioxidant System by the 5- and 6-Membered Heterocycle-Based Nitroxides.基于 5 元和 6 元杂环的氮氧自由基对人红细胞抗氧化系统的调节作用。
Molecules. 2024 Jun 20;29(12):2941. doi: 10.3390/molecules29122941.
8
Histidine-Bound Dinitrosyl Iron Complexes: Antioxidant and Antiradical Properties.组氨酸结合的双亚硝酰基铁配合物:抗氧化和抗自由基性质。
Int J Mol Sci. 2023 Dec 7;24(24):17236. doi: 10.3390/ijms242417236.
9
Insights into the function of cytoglobin.细胞血红素蛋白功能的研究进展
Biochem Soc Trans. 2023 Oct 31;51(5):1907-1919. doi: 10.1042/BST20230081.
10
Modified Graphite Pencil Electrode Based on Graphene Oxide-Modified FeO for Ferrocene-Mediated Electrochemical Detection of Hemoglobin.基于氧化石墨烯修饰的FeO的改性石墨铅笔电极用于二茂铁介导的血红蛋白电化学检测
ACS Omega. 2023 Mar 24;8(13):11880-11888. doi: 10.1021/acsomega.2c07023. eCollection 2023 Apr 4.
将酪氨酸残基工程化到血红蛋白中可增强血红素还原,减少氧化应激,并增加基于血红蛋白的血液代用品的血管保留。
Free Radic Biol Med. 2019 Apr;134:106-118. doi: 10.1016/j.freeradbiomed.2018.12.030. Epub 2018 Dec 27.
4
Novel Redox Active Tyrosine Mutations Enhance the Regeneration of Functional Oxyhemoglobin from Methemoglobin: Implications for Design of Blood Substitutes.新型氧化还原活性酪氨酸突变增强了从高铁血红蛋白向功能性氧合血红蛋白的再生:对血液代用品设计的启示。
Adv Exp Med Biol. 2018;1072:221-225. doi: 10.1007/978-3-319-91287-5_35.
5
Comparison of the oxidative reactivity of recombinant fetal and adult human hemoglobin: implications for the design of hemoglobin-based oxygen carriers.重组胎儿和成人血红蛋白的氧化反应性比较:对血红蛋白基氧载体设计的影响。
Biosci Rep. 2018 Jul 2;38(4). doi: 10.1042/BSR20180370. Print 2018 Aug 31.
6
Rhabdomyolysis in Earthquake Victims in Nepal.尼泊尔地震遇难者中的横纹肌溶解症
Kidney Int Rep. 2016 Dec 9;2(2):127-129. doi: 10.1016/j.ekir.2016.11.009. eCollection 2017 Mar.
7
Current Challenges in the Development of Acellular Hemoglobin Oxygen Carriers by Protein Engineering.通过蛋白质工程开发无细胞血红蛋白氧载体的当前挑战。
Shock. 2019 Oct;52(1S Suppl 1):28-40. doi: 10.1097/SHK.0000000000001053.
8
Mechanisms of Toxicity and Modulation of Hemoglobin-based Oxygen Carriers.基于血红蛋白的氧载体的毒性机制及其调控。
Shock. 2019 Oct;52(1S Suppl 1):41-49. doi: 10.1097/SHK.0000000000001044.
9
SANGUINATE (PEGylated Carboxyhemoglobin Bovine): Mechanism of Action and Clinical Update.血源素(聚乙二醇化牛羧基血红蛋白):作用机制与临床进展
Artif Organs. 2017 Apr;41(4):346-350. doi: 10.1111/aor.12934.
10
Fetal hemoglobin is much less prone to DNA cleavage compared to the adult protein.与成人血红蛋白相比,胎儿血红蛋白更不易发生DNA裂解。
Redox Biol. 2017 Aug;12:114-120. doi: 10.1016/j.redox.2017.02.008. Epub 2017 Feb 12.